• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Rimidi Launches 2.0 Platform, Unlocking New Possibilities in Healthcare Innovations

by Jasmine Pennic 03/19/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Rimidi Launches 2.0 Platform, Unlocking New Possibilities in Healthcare Innovations

What You Should Know: 

– Rimidi, a digital health company specializing in remote patient monitoring and chronic disease management, has unveiled Rimidi 2.0, a significant platform upgrade designed to address the increasing complexities of modern healthcare delivery.

-* Built on a robust microservices architecture, Rimidi 2.0 offers enhanced scalability, strengthened data security, expanded device integration, and a flexible framework primed for the rapid adoption of emerging technologies like AI. This next-generation platform empowers both clinical and IT teams with a future-ready solution to optimize patient care, streamline workflows, and improve operational efficiency.

Key Enhancments & Capabilities

Rimidi 2.0’s microservices framework allows for easy expansion and enhancement over time. By breaking down the platform into smaller, independent services, healthcare organizations can quickly add capabilities without disrupting existing workflows, maximizing their technology investments.

Key enhancements and features of Rimidi 2.0 include:

  • Seamless Integration and Data Standardization:
    • Expanded connectivity with a wider range of medical devices.
    • Standardized data from diverse sources for clinically actionable insights.
    • Reduced clinician workload and improved care coordination.
  • Enhanced Clinical Trial Support:
    • New tools for standardized and streamlined clinical trial data collection.
    • Support for multi-site research efforts, already deployed at 12 academic medical centers.
    • Secure, de-identified data for study participants.
    • Normalized data from diverse devices and locations, accelerating research timelines.
  • Optimized Financial Sustainability:
    • Strengthened support for fee-for-service billable programs.
    • Expanded capabilities for CCM, RPM, and other reimbursable care models.
    • Enhanced ability to adapt to new reimbursement policies.
    • Improved patient engagement and health outcomes.

“Virtual care is evolving faster than ever, and healthcare organizations face mounting pressure to meet new demands while delivering excellent patient care,” said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. “Rimidi 2.0 supports today’s needs and is designed to scale as the industry changes. This ensures providers can stay agile with expanding payment models, new workflows, and the rapid adoption of connected health devices.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Rimidi

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |